Background
==========

Aggressive periodontitis (AgP) is a complex multifactorial infectious disease of tooth-supporting tissues. It is characterized by rapid progressive damage of tooth-supporting tissues, such as alveolar bone loss with pocket formation, gingival inflammation, and recession \[[@b1-medscimonit-21-1617]\]. This disease is the major cause of tooth loss in populations worldwide. Current evidence indicates that the interactions among different risk factors, such as microbiological factors, immunological factors, life habits, and genetic factors, are critical during periodontitis development \[[@b2-medscimonit-21-1617]\].

Interleukin-1 (IL-1) is a critical cytokine involved in most inflammatory responses, and it has been implicated in mediating acute and serious inflammatory diseases \[[@b3-medscimonit-21-1617]\]. The IL-1 gene family includes 2 functionally similar types (IL-1α and IL-1β), which are located in a cluster of human chromosome 2q13 \[[@b4-medscimonit-21-1617]\]. IL-1β is produced by many cell types, including macrophages, monocytes, and T cells. Many recent studies have proven that high expression of IL-1β may be associated with inflammatory diseases, such as arthritis and bowel inflammation, and cancer conditions, such as gastric and oral cancers \[[@b5-medscimonit-21-1617]--[@b7-medscimonit-21-1617]\]. IL-1β has been reported to be a central pro-inflammatory cytokine of the immune system, as well as an important mediator during the pathogenesis of periodontal diseases \[[@b8-medscimonit-21-1617],[@b9-medscimonit-21-1617]\]. A number of molecular studies proved that the IL-1β levels of gingival crevicular fluid and gingival tissue are significantly higher in AgP subjects \[[@b10-medscimonit-21-1617]--[@b12-medscimonit-21-1617]\].

Single-nucleotide polymorphism (SNP) is one of the most important types of gene mutation that influences gene transcription and translation, and it promotes the susceptibility of disease development \[[@b13-medscimonit-21-1617],[@b14-medscimonit-21-1617]\]. IL-1β −511C\>T and +3954C\>T polymorphisms are the 2 most common *loci* that are thought to change the susceptibility of individuals to inflammation-induced periodontal diseases.

In 2002, Tai et al. \[[@b15-medscimonit-21-1617]\] conducted the first study about the 2 polymorphisms of the IL-1β gene and AgP risk in a hospital-based Japanese study. As of this writing, several epidemiological studies have investigated the association between IL-1β −511C\>T and +3954C\>T polymorphisms and AgP susceptibility. In 2008, Nikolopoulos et al. \[[@b16-medscimonit-21-1617]\] reported a recent meta-analysis that involved only 5--511C\>T polymorphism and 16 +3954C\>T polymorphism case-control studies. Several new studies had been published, but the results are still controversial. Considering the importance of IL-1β in the development of AgP, we conducted a meta-analysis of all relevant studies to clarify the association between IL-1β −511C\>T and +3954C\>T polymorphisms and AgP risk.

Material and Methods
====================

All methods used in this meta-analysis were performed following the guidelines of Meta-analysis of Observational Studies in Epidemiology \[[@b17-medscimonit-21-1617]\].

Search strategy
---------------

Two online electronic databases (PubMed and Embase) were searched using the terms "periodontitis," "aggressive periodontitis," "AgP," "Interleukin-1," "IL-1," "polymorphism," "variant," and their combined phrases for all studies on the association between IL-1β polymorphisms and AgP risk, up to February 1, 2015. All selected studies satisfied the following inclusion criteria: (1) case-control or cohort design study on IL-1β polymorphisms and AgP; (2) focus on IL-1β −511C\>T and +3954C\>T polymorphisms; and (3) sufficient genotype frequency to estimate the odds ratio (OR) and 95% confidence interval (CI). Exclusion criteria included review articles, case reports, and animal models. The largest or most recently published studies were selected when similar or overlapping data were present.

Data extraction
---------------

Two reviewers (Hu and Liu) independently extracted the following information from all collected studies: the first author's name, publication date, country and racial descent (categorized as either Asian or white), sources of controls, number of cases and controls with different genotypes, Hardy-Weinberg equilibrium (HWE), and minor allele frequency. A third reviewer (Niu) was introduced to adjudicate any discrepancies in each item for consistency.

Statistical analysis
--------------------

ORs with 95% CIs were calculated to evaluate the strength of the association between the IL-1β polymorphisms and AgP risk. For IL-1β −511C\>T and +3954C\>T polymorphisms, the pooled ORs were obtained for allele contrast (T *vs.* C), co-dominant model (CT *vs.* CC and TT *vs.* CC), dominant model (CT+TT *vs.* CC), and recessive model (TT *vs.* CC+CT). In subgroup analysis, HWE, ethnicity, and study design were also analyzed statistically. Heterogeneity was calculated based on Cochran's Q and *I^2^* statistics \[[@b18-medscimonit-21-1617]\]. ORs were estimated using a random-effects model (DerSimonian and Laird method) when *I^2^* was greater than 50%; otherwise, a fixed-effects model (Mantel-Haenszel method) was used \[[@b19-medscimonit-21-1617]\]. Cumulative meta-analyses and sensitivity analysis were conducted to evaluate the stability of the results by sequentially removing each study in each model. Potential publication bias was analyzed by Egger's linear regression and Begg's funnel plot \[[@b20-medscimonit-21-1617]\]. Statistical analysis was performed using STATA version 11.0 (Stata Corporation, College Station, TX, USA), with 2-sided *P* values. *P*\<0.05 considered significant.

Results
=======

Study characteristics
---------------------

A total of 342 articles were obtained through the literature search. The flow chart of study selection is shown in [Figure 1](#f1-medscimonit-21-1617){ref-type="fig"}. In the first step of title and duplicate screening, 288 studies were excluded. In the remaining 54 studies, 34 studies were excluded (5 were reviews, 7 focused on molecular research, 7 were about the research polymorphism locus, and 15 were not about the relevant gene and AgP risk). Twenty publications with sufficient data were collected in our meta-analysis \[[@b15-medscimonit-21-1617],[@b21-medscimonit-21-1617]--[@b39-medscimonit-21-1617]\]. Out of these 20 articles, 8 case-control studies with 522 cases and 683 controls described the association between IL-1β −511C\>T polymorphism and AgP risk \[[@b15-medscimonit-21-1617],[@b23-medscimonit-21-1617],[@b25-medscimonit-21-1617],[@b27-medscimonit-21-1617],[@b30-medscimonit-21-1617],[@b32-medscimonit-21-1617]--[@b34-medscimonit-21-1617]\], and 22 case-control studies involving 965 cases and 1234 controls focused on the relationship of IL-1β +3954C\>T polymorphism and AgP susceptibility \[[@b15-medscimonit-21-1617], [@b21-medscimonit-21-1617]--[@b39-medscimonit-21-1617]\]. Only 2 studies deviated from the finding of HWE in IL-1β +3954C\>T polymorphism \[[@b35-medscimonit-21-1617],[@b37-medscimonit-21-1617]\]. The characteristics of the selected studies are summarized in [Table 1](#t1-medscimonit-21-1617){ref-type="table"}.

Quantitative analysis
---------------------

### For IL-1β −511C\>T polymorphism

Eight related publications (522 cases and 683 controls) reported on the association between IL-1β −511C\>T polymorphism and AgP risk \[[@b15-medscimonit-21-1617],[@b23-medscimonit-21-1617],[@b25-medscimonit-21-1617],[@b27-medscimonit-21-1617],[@b30-medscimonit-21-1617],[@b32-medscimonit-21-1617]--[@b34-medscimonit-21-1617]\]. Three studies described Asian populations \[[@b15-medscimonit-21-1617],[@b25-medscimonit-21-1617],[@b32-medscimonit-21-1617]\], and 5 studies described white populations \[[@b23-medscimonit-21-1617],[@b27-medscimonit-21-1617],[@b30-medscimonit-21-1617],[@b33-medscimonit-21-1617],[@b34-medscimonit-21-1617]\]. Overall, no significant association between IL-1β −511C\>T polymorphism and AgP risk was found in this meta-analysis \[T *vs.* C: OR=1.069, 95% CI=0.901--1.268, *P*=0.443, *I^2^*=0%; CT *vs.* CC: OR=0.921, 95% CI=0.699--1.212, *P*=0.556, *I^2^*=8.9%; TT *vs.* CC: OR=1.064, 95% CI=0.747--1.515, *P*=0.732, *I^2^*=5.6%; CT+TT *vs.* CC: OR=0.990, 95% CI=0.764--1.283, *P*=0.938, *I^2^*=3.9%; TT *vs.* CC+CT: OR=1.229, 95% CI=0.919--1.643, *P*=0.164, *I^2^*=0.0%\]. In subsequent analysis without the 2 studies that deviated from the HWE, consistent results were found in all 5 genotype models. In the stratified analysis of ethnicity and study design, a similar lack of associations was found between IL-1β −511C\>T polymorphism and AgP risk ([Table 2](#t2-medscimonit-21-1617){ref-type="table"}).

Sensitivity and cumulative analyses showed that no single study qualitatively changed the pooled ORs, indicating that the results of this meta-analysis were highly stable. Funnel plot and Egger's test were performed to estimate publication bias, and no asymmetrical evidence was revealed. The results were further supported by data analysis using Egger's test \[T *vs.* C: *P*=0.10; CT *vs.* CC: *P*=0.23; TT *vs.* CC: *P*=0.17; CT+TT *vs.* CC: *P*=0.61; TT *vs.* CC+CT: *P*=0.10\].

### For IL-1β +3954C\>T polymorphism

The 20 articles included 22 case-control studies (965 cases and 1234 controls) focused on IL-1β +3954C\>T polymorphism \[[@b15-medscimonit-21-1617],[@b21-medscimonit-21-1617]--[@b39-medscimonit-21-1617]\]. Five studies focused on Asian populations \[[@b15-medscimonit-21-1617],[@b22-medscimonit-21-1617],[@b25-medscimonit-21-1617],[@b32-medscimonit-21-1617],[@b36-medscimonit-21-1617]\], and 15 studies described white populations \[[@b21-medscimonit-21-1617],[@b23-medscimonit-21-1617],[@b27-medscimonit-21-1617]--[@b31-medscimonit-21-1617],[@b33-medscimonit-21-1617]--[@b35-medscimonit-21-1617],[@b37-medscimonit-21-1617]--[@b39-medscimonit-21-1617]\], and 2 studies assessed mixed populations \[[@b24-medscimonit-21-1617],[@b26-medscimonit-21-1617]\]. No significant associations were found in any of the 5 models \[T *vs.* C: OR=0.966, 95% CI=0.696--1.341, *P*=0.836, *I^2^*=72.8%; CT *vs.* CC: OR=0.936, 95% CI=0.761--1.151, *P*=0.531, *I^2^*=24.4%; TT *vs.* CC: OR=0.892, 95% CI=0.464--1.715, *P*=0.732, *I^2^*=54.0%; CT+TT *vs.* CC: OR=1.026, 95% CI=0.795--1.323, *P*=0.845, *I^2^*=32.9% ([Figure 2](#f2-medscimonit-21-1617){ref-type="fig"}); TT *vs.* CC+CT: OR=0.864, 95% CI=0.436--1.713, *P*=0.675, *I^2^*=60.9%\] ([Table 2](#t2-medscimonit-21-1617){ref-type="table"}). Further stratified and subgroup analyses according to ethnicity and control design were conducted, and no significant association was found. Heterogeneities were observed in the following 3 models: T *vs.* C, TT *vs.* CC, and TT *vs.* CC+CT. Meta-regression analyses were conducted, and no significant key factors for heterogeneity were identified. However, subgroup analysis by ethnicity and control design revealed the heterogeneities in some models.

Sensitivity and publication bias were also determined. No conspicuous changes in the pooled ORs ([Figure 3](#f3-medscimonit-21-1617){ref-type="fig"} for CT+TT *vs.* CC model) were detected, and publication bias was not observed \[T *vs.* C: *P*=0.96; CT *vs.* CC: *P*=0.90; TT *vs.* CC: *P*=0.96; CT+TT *vs.* CC: *P*=0.05 ([Figure 4](#f4-medscimonit-21-1617){ref-type="fig"}); TT *vs.* CC+CT: *P*=0.10\].

Discussion
==========

In 1999, the new criteria for classification of periodontal disease were published. AgP is a type of periodontal disease that includes 2 severe subvarieties: generalized aggressive periodontitis and localized aggressive periodontitis. Sometimes, AgP exhibits the following features: patients are always young people with rapid loss of attachment and bone destruction, and familial association. A number of etiology studies have shown that the occurrence of AgP mainly includes 2 aspects: (1) microbial factors, particularly *Actinobacillus actinomycetemcomitans* infection, which is a critical pathogen in AgP patients; and (2) human immunity defects, which are often associated with AgP risk. In past years, the differences in periodontitis among individuals were not always interpreted to oral hygiene status. Currently, genetic factors are considered strong determinants of this disease. Gene mutation, particularly SNPs, may change the expression level of a protein and then alter the immune response, thereby influencing patients' susceptibility to AgP development.

IL-1, with its proinflammatory properties, has been implicated in the pathogenesis of periodontitis. Moreover, it is involved in inflammation during AgP development. In 2002, Tai et al. \[[@b15-medscimonit-21-1617]\] reported the first negative result about the association between IL-1β −511C\>T or +3954C\>T polymorphism and AgP risk. Since then, a substantial number of studies on the association between IL-1β −511C\>T or +3954C\>T polymorphism and AgP risk have been published, but the results were inconsistent. Quappe et al. \[[@b24-medscimonit-21-1617]\] found that the T allele of IL-1β +3954C\>T polymorphism is significantly associated with AgP in Chilean patients (OR=2.86, 95% CI=1.06--7.71, *P*=0.03). Similar results were also revealed in English patients with IL-1β +3954C\>T polymorphism\[[@b23-medscimonit-21-1617]\]. Furthermore, the IL-1β −511 CT heterozygote exhibited a significantly positive association in a male Chinese AgP group (OR=3.16, 95% CI=1.01--9.89, *P*=0.048) \[[@b25-medscimonit-21-1617]\]. However, numerous studies obtained negative results.

In our meta-analysis, no significant association between IL-1β −511C\>T or +3954C\>T polymorphism and AgP risk was found in overall pools. Further analyses on gene models and groups stratified by ethnicity and control design were conducted to obtain more precise results. This investigation could provide a useful summary of the relationship between IL-1β −511C\>T or +3954C\>T polymorphism and AgP risk, and help improve clinical understanding needed to construct a molecular basis for the diagnosis and treatment of AgP.

However, some limitations should be addressed. First, the sample size was still relatively small for each polymorphism, particularly for IL-1β −511C\>T locus, which decreased the statistical power of results or resulted in a different conclusion. Second, a certain degree of heterogeneity existed in the IL-1β +3954C\>T locus in the 4 genetic models. Subgroup analyses indicated that this heterogeneity could be explained by ethnicity and control design. Other factors, such as environment, living habits, and age, might contribute to heterogeneity, but these interactions were not investigated in this study because of unavailable data. Third, only 2 polymorphisms were analyzed in our meta-analysis. Haplotype analyses of the 2 polymorphisms were not conducted because of insufficient haplotype data from the included reports, although haplotype analysis may be more precise and credible. Despite these limitations, no qualitative changes were found in sensitivity and publication bias in this meta-analysis, thereby indicating that the results on the possible association between IL-1β −511C\>T or +3954C\>T polymorphism and AgP risk were statistically robust.

Conclusions
===========

The results of this meta-analysis suggest that IL-1β −511C\>T and +3954C\>T polymorphisms are not key factors in AgP development. Considering the importance of IL-1β during AgP progression, more large-scale case-control studies are necessary to explore the association and potential haplotype and gene − environment interactions between IL-1β polymorphisms and AgP risk.
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###### 

Characteristics of case-control studies on IL-1β −511C\>T and +3954C\>T polymorphisms and AgP risk included in the meta-analysis.

  First author        Year   Country     Racial descent   Source of controls    Case   Control   Genotype distribution   P for HWE[\*](#tfn1-medscimonit-21-1617){ref-type="table-fn"}   MAF                                             
  ------------------- ------ ----------- ---------------- --------------------- ------ --------- ----------------------- --------------------------------------------------------------- --------- --------- --------- --------- ------- -------
  Tai                 2002   Japan       Asian            Hospital control      47     97        13                      25                                                              9         31        51        15        0.425   0.418
                                                                                                                                                                                                                                         
  Li                  2004   China       Asian            Population controls   122    95        33                      55                                                              34        28        44        23        0.488   0.474
                                                                                                                                                                                                                                         
  Scapoli             2005   Italian     Caucasians       Hospital control      39     96        13                      23                                                              3         38        51        7         0.068   0.339
                                                                                                                                                                                                                                         
  Brett               2005   English     Caucasians       Population controls   50     100       23                      21                                                              6         51        39        10        0.533   0.295
                                                                                                                                                                                                                                         
  Havemose-Poulsen    2007   Denmark.    Caucasians       Hospital control      44     25        15                      19                                                              11        11        13        1         0.233   0.300
                                                                                                                                                                                                                                         
  Shete               2010   India       Asian            Population controls   54     101       9                       15                                                              30        9         43        49        0.921   0.698
                                                                                                                                                                                                                                         
  Karasneh            2011   Jordan      Caucasian        Population controls   80     80        20                      32                                                              28        11        40        29        0.633   0.613
                                                                                                                                                                                                                                         
  Schulz              2011   Germany     Caucasian        No available          86     89        37                      36                                                              13        36        40        13        0.728   0.371
                                                                                                                                                                                                                                         
                                                                                                 **C/C**                 **C/T**                                                         **T/T**   **C/C**   **C/T**   **T/T**           
                                                                                                                                                                                                                                         
  Tai                 2002   Japan       Asian            Hospital control      47     97        45                      2                                                               0         88        8         0         0.670   0.042
                                                                                                                                                                                                                                         
  Gonzales1           2003   European    Caucasians       Hospital control      28     33        15                      10                                                              3         17        12        4         0.424   0.303
                                                                                                                                                                                                                                         
  Gonzales2           2003   American    Caucasians       Hospital control      16     14        10                      4                                                               2         9         3         2         0.109   0.250
                                                                                                                                                                                                                                         
  Anusaksathien       2003   Thai        Asian            Hospital control      26     43        24                      2                                                               0         42        1         0         0.939   0.012
                                                                                                                                                                                                                                         
  Quappe              2004   Chile       Mixed            Population controls   36     75        25                      11                                                              0         63        10        2         0.066   0.093
                                                                                                                                                                                                                                         
  Scapoli             2005   Italian     Caucasians       Hospital control      40     96        24                      15                                                              1         42        43        11        0.999   0.339
                                                                                                                                                                                                                                         
  Li                  2004   China       Asian            Population controls   122    95        114                     7                                                               1         93        2         0         0.917   0.011
                                                                                                                                                                                                                                         
  Moreira             2005   Brazilian   Mixed            Hospital control      46     31        34                      12                                                              0         24        7         0         0.479   0.113
                                                                                                                                                                                                                                         
  Brett               3005   English     Caucasians       Population controls   49     98        28                      9                                                               12        58        32        8         0.246   0.245
                                                                                                                                                                                                                                         
  Sakellari           2006   Greek       Caucasians       Hospital control      46     90        26                      16                                                              4         50        35        5         0.725   0.250
                                                                                                                                                                                                                                         
  Droździk            2006   Poland      Caucasians       No available          20     52        15                      5                                                               0         31        19        2         0.662   0.221
                                                                                                                                                                                                                                         
  Havemose-Poulsen1   2007   Denmark.    Caucasians       Hospital control      18     25        9                       7                                                               2         16        9         0         0.272   0.180
                                                                                                                                                                                                                                         
  Havemose-Poulsen2   2007   Denmark.    Caucasians       Hospital control      27     25        19                      7                                                               1         16        9         0         0.272   0.180
  Guzeldemir          2008   Turkey      Caucasians       Population controls   31     31        19                      11                                                              1         0         7         24        0.479   0.887
                                                                                                                                                                                                                                         
  Shete               2010   India       Asian            Population controls   54     101       41                      13                                                              0         75        25        1         0.489   0.134
                                                                                                                                                                                                                                         
  Karasneh            2011   Jordan      Caucasian        Population controls   80     80        45                      32                                                              3         41        33        6         0.856   0.281
                                                                                                                                                                                                                                         
  Schulz              2011   Germany     Caucasian        No available          82     88        51                      25                                                              6         50        33        5         0.884   0.244
                                                                                                                                                                                                                                         
  Shibani             2011   Syria       Caucasian        Hospital control      32     35        15                      14                                                              3         22        8         5         0.017   0.257
                                                                                                                                                                                                                                         
  Masamatti           2012   Indian      Asian            Hospital control      30     30        19                      10                                                              1         21        7         2         0.227   0.183
                                                                                                                                                                                                                                         
  Yücel               2013   Turkish     Caucasian        Hospital control      56     47        29                      19                                                              8         32        9         6         0.002   0.223
                                                                                                                                                                                                                                         
  Ayazi               2013   Iran        Caucasian        Population controls   26     25        10                      0                                                               16        14        7         4         0.096   0.300
                                                                                                                                                                                                                                         
  Ebadian             2013   Iran        Caucasian        Hospital control      53     48        32                      21                                                              0         24        20        4         0.954   0.292

HWE in control; MAF -- minor allele frequency in control group.

###### 

Summary ORs and 95% CI of IL-1β −511C\>T and +3954 C\>T polymorphism and AgP risk.

  −511C\>T              T *vs.* C               CT *vs.* CC               TT *vs.* CC               CT+TT *vs.* CC               TT *vs.* CC+CT                                                                                                                                                            
  ---------------- ---- ----------------------- ------------------------- ------------------------- ---------------------------- ---------------------------- --------------- ------- ------ ------- --------------- ------- ------ ------- --------------- ------- ------ ------- --------------- ------- ------
  Total            8    1.069                   0.901 --1.268             0.443                     0.0                          0.921                        0.699 --1.212   0.556   8.9    1.064   0.747 --1.515   0.732   5.6    0.990   0.764 --1.283   0.938   3.9    1.229   0.919 --1.643   0.164   0.0
  Ethnicity                                                                                                                                                                                                                                                                                                
  Asian            3    1.101                   0.850 --1.428             0.465                     0.0                          0.907                        0.577 --1.425   0.672   43.4   1.080   0.644 --1.811   0.770   0.0    0.997   0.653 --1.522   0.987   17.8   1.268   0.847 --1.900   0.249   0.0
  Caucasian        5    1.045                   0.833 --1.311             0.705                     20.7                         0.929                        0.656 --1.314   0.676   3.3    1.050   0.646 --1.706   0.845   30.8   0.986   0.710 --1.369   0.932   17.5   1.188   0.782 --1.804   0.419   0.0
  Design                                                                                                                                                                                                                                                                                                   
  HB               3    1.299                   0.937 --1.800             0.117                     0.0                          1.202                        0.730 --1.979   0.470   0.0    1.926   0.904 --4.102   0.089   11.9   1.331   0.822 --2.154   0.245   0.0    1.723   0.880 --3.374   0.112   28.2
  PB               4    1.004                   0.802 --1.259             0.970                     0.0                          0.797                        0.541 --1.174   0.251   49.5   0.882   0.562 --1.385   0.586   3.5    0.865   0.603 --1.242   0.432   40.7   1.157   0.816 --1.641   0.413   0.0
  **+3954 C\>T**        **T** ***vs.*** **C**   **CT** ***vs.*** **CC**   **TT** ***vs.*** **CC**   **CT+TT** ***vs.*** **CC**   **TT** ***vs.*** **CC+CT**                                                                                                                                                
  Total            22   0.966                   0.696 --1.341             0.836                     72.8                         0.936                        0.761 --1.151   0.531   24.4   0.892   0.464 --1.715   0.732   54.0   1.026   0.795 --1.323   0.845   32.9   0.864   0.436 --1.713   0.675   60.9
  HWE              20   0.922                   0.643 --1.32              0.659                     74.3                         0.852                        0.685 --1.509   0.149   8.2    0.818   0.378 --1.770   0.610   59.0   0.866   0.707 --1.060   0.162   27.9   0.843   0.377 --1.886   0.796   65.1
  Ethnicity                                                                                                                                                                                                                                                                                                
  Asian            5    1.118                   0.702 --1.780             0.639                     9.7                          1.199                        0.713 --2.015   0.494   0.0    0.877   0.183 --4.205   0.870   0.0    1.174   0.706 --1.952   0.536   0.5    0.816   0.172 --3.878   0.799   0.0
  Caucasian        15   0.870                   0.576 --1.314             0.508                     80.1                         0.823                        0.648 --1.045   0.109   22.0   0.885   0.416--1.883    0.752   63.5   0.931   0.686 --1.263   0.646   40.3   0.880   0.402 --1.927   0.749   68.9
  Mixed            2    1.473                   0.770 --2.818             0.242                     0.0                          1.875                        0.911 --3.859   0.531   20.9   0.498   0.593 --1.179   0.656   NA     1.723   0.848 --3.501   0.133   0.0    0.403   0.019 --8.608   0.560   NA
  Design                                                                                                                                                                                                                                                                                                   
  HB               13   0.971                   0.777 --1.213             0.796                     6.8                          1.062                        0.797 --1.415   0.681   0.0    0.843   0.495 --1.434   0.529   0.0    1.020   0.777 --1.339   0.886   0.0    0.795   0.471 --1.341   0.389   0.0
  PB               7    0.966                   0.386 --2.417             0.941                     90.5                         0.911                        0.463 --1.792   0.787   59.6   0.678   0.129 --3.557   0.646   80.0   1.128   0.595 --2.137   0.712   66.4   0.764   0.136 --4.288   0.760   83.9
  Other            2    0.798                   0.510 --1.250             0.325                     0.0                          0.687                        0.391 --1.210   0.194   24.4   0.981   0.318 --3.030   0.973   0.0    0.714   0.417 --1.225   0.221   0.0    1.117   0.367 --3.396   0.845   0.0

Number of comparisons; PB -- population based; HB -- hospital based.
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